Oxidative/nitrosative stress selectively altered A(2B) adenosine receptors in chronic obstructive pulmonary disease

FASEB J. 2010 Apr;24(4):1192-204. doi: 10.1096/fj.09-139485. Epub 2009 Dec 14.

Abstract

The primary aim of this study was to investigate adenosine receptors (ARs) in bronchoalveolar lavage (BAL) macrophages from patients with chronic obstructive pulmonary disease (COPD) and age-matched healthy smokers. A(2B)ARs were significantly decreased in BAL macrophages from patients with COPD when compared with healthy smokers. The effect of proinflammatory cytokines and oxidative/nitrosative stress on AR expression and function in U937 cells before and after PMA treatment was evaluated. IL-1beta and TNF-alpha treatment up-regulated A(2A)- and A(3)ARs but not A(1)- or A(2B)ARs, whereas IL-6 did not modify AR expression. In contrast, oxidative/nitrosative stress selectively decreased A(2B)AR expression, which was associated with a reduction in the potency of the adenosine agonist 5'-N-ethylcarboxamideadenosine (NECA) to induce cAMP. Further, the ability of NECA to enhance cell proliferation was increased after oxidative/nitrosative stress. The specific involvement of A(2B)ARs was investigated by using potent and selective A(2B)AR antagonist and by A(2B)AR knockdown using siRNA and demonstrated responses similar to those obtained with oxidative/nitrosative stress. N-acetylcysteine (NAC), an antioxidant agent, counteracted the decrease in A(2B)AR expression, as well as the altered NECA effects on cAMP and cell proliferation. These findings highlight the central role of A(2B)ARs in alveolar macrophages, suggesting that their modulation could represent an innovative pharmacological strategy to manage COPD.-Varani, K., Caramori, G., Vincenzi, F., Tosi, A., Barczyk, A., Contoli, M., Casolari, P., Triggiani, M., Hansel, T., Leung, E., MacLennan, S., Barnes, P. J., Fan Chung, K., Adcock, I., Papi, A., Borea, P. A. Oxidative/nitrosative stress selectively altered A(2B) adenosine receptors in chronic obstructive pulmonary disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Adenosine A2 Receptor Agonists
  • Adenosine A2 Receptor Antagonists
  • Adenosine-5'-(N-ethylcarboxamide) / pharmacology
  • Aged
  • Bronchoalveolar Lavage
  • Cell Proliferation / drug effects
  • Cyclic AMP / genetics
  • Cyclic AMP / metabolism
  • Cytokines / metabolism
  • Cytokines / pharmacology
  • Down-Regulation*
  • Female
  • Free Radical Scavengers / pharmacology
  • Gene Knockdown Techniques
  • Humans
  • Macrophages, Alveolar / metabolism*
  • Macrophages, Alveolar / pathology
  • Male
  • Middle Aged
  • Oxidative Stress*
  • Pulmonary Disease, Chronic Obstructive / genetics
  • Pulmonary Disease, Chronic Obstructive / metabolism*
  • Pulmonary Disease, Chronic Obstructive / pathology
  • Pulmonary Disease, Chronic Obstructive / therapy
  • RNA, Small Interfering / pharmacology
  • Receptor, Adenosine A2B / biosynthesis*
  • Receptor, Adenosine A2B / genetics
  • Smoking / metabolism
  • Smoking / pathology
  • U937 Cells
  • Vasodilator Agents / pharmacology

Substances

  • Adenosine A2 Receptor Agonists
  • Adenosine A2 Receptor Antagonists
  • Cytokines
  • Free Radical Scavengers
  • RNA, Small Interfering
  • Receptor, Adenosine A2B
  • Vasodilator Agents
  • Adenosine-5'-(N-ethylcarboxamide)
  • Cyclic AMP
  • Acetylcysteine